Αποτελέσματα Αναζήτησης
1 Νοε 2020 · A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome
20 Αυγ 2021 · This guideline covers obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS), and chronic obstructive pulmonary disease (COPD) with OSAHS overlap syndrome, providing advice on investigating and managing these related conditions.
Obesity hypoventilation syndrome (OHS) is an undesirable consequence of obesity, defined as daytime hypoventilation, sleep disorder breathing and obesity; during the past few years the prevalence of extreme obesity has markedly increased worldwide consequently increasing the prevalence of OHS.
Management of OSAHS may require input from ENT (Ear, Nose and Throat) and maxillofacial surgical specialities, particularly when conventional treatments such as CPAP or oral devices have failed or if a patient has large tonsils.
In clinical trials, ‘surgical success’ is defined as >50% reduction in AHI with residual AHI <20 events/h, and ‘cure’ is defined as residual AHI <5. Surgical success rates of upper airway surgeries in treating OSA range from 40% to 60%, with a low cure rate of 16%. 46
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive and sleep-disordered breathing.
3 Νοε 2017 · Obstructive Sleep Apnea has been receiving more and more attention while the diagnostic rate of Obesity Hypoventilation Syndrome is not high. Few studies directly evaluated the relationship between them. We systematically analyzed the relevance of the two diseases.
